Clears

MINNEAPOLIS, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA has cleared the Horizon 3.0 (with or…

Digital Health Software Platform Reduces Time and Cost of Imaging and Improves Outcomes Across Diverse Patient Populations DALLAS--(BUSINESS WIRE)--#AI--MedCognetics, Inc. today announced it has received U.S Food and Drug Administration…